Related Experiment Videos
Episodic hormone secretion during sleep in Kleine-Levin syndrome: evidence for hypothalamic dysfunction
N Gadoth1, Z Dickerman, M Bechar
1Department of Neurology, Beilinson Medical Center, Petah Tiqva, Israel.
Brain & Development
|January 1, 1987
Summary
Kleine-Levin syndrome may stem from hypothalamic dysfunction, as suggested by abnormal pituitary hormone secretion patterns during hypersomnic attacks. This study provides laboratory evidence supporting the hypothalamic origin of this rare sleep disorder.
Area of Science:
- Neuroendocrinology
- Sleep Medicine
- Hormone Research
Background:
- Kleine-Levin syndrome (KLS) is a rare disorder characterized by recurrent episodes of hypersomnolence and cognitive/behavioral changes.
- The underlying pathophysiology of KLS remains poorly understood, with hypothalamic dysfunction being a long-standing hypothesis.
- This study investigates neuroendocrine function during a KLS episode to explore potential hypothalamic involvement.
Observation:
- Acute hypothalamic-pituitary function tests were performed on a 23-year-old male with KLS during a hypersomnic attack.
- Nocturnal secretory patterns of growth hormone, 11-hydroxycorticosteroids (11-OHCS), prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid-stimulating hormone (TSH) were analyzed.
- Specific tests included insulin tolerance test, gonadotropin-releasing hormone (LRH), adrenocorticotropic hormone (ACTH), and thyrotropin-releasing hormone (TRH) stimulation tests.
Findings:
- Paradoxical growth hormone response to TRH stimulation was observed.
- Borderline high basal plasma prolactin levels with a normal TRH response were noted.
- Abnormalities in the nocturnal secretion of LH, 11-OHCS, and prolactin were identified.
Implications:
- The observed hormonal abnormalities suggest a dysfunction in the hypothalamic regulation of pituitary hormones in KLS.
- This study presents the first laboratory evidence supporting the hypothesis that Kleine-Levin syndrome is linked to hypothalamic dysfunction.
- These findings open new avenues for understanding KLS pathophysiology and potential therapeutic targets.